Global Gastrointestinal (GI) Stent Market Size, Share & Trends Report Segmented by Product Type (Biliary, Colonic, Duodenal, Esophageal, Pancreatic), Application (GI Cancer, Biliary Disease, Colorectal Cancer), Material (Plastic, Metal), End-user Analysis & Regional Forecast to 2030
The global gastrointestinal stent market is expected to grow at a CAGR of ~6% during the forecast period. Rising incidence of gastrointestinal cancers and digestive tract obstructions coupled with the increasing preference for minimally invasive procedures, advancements in stent design and materials, and a rising geriatric population prone to GI disorders, are some of the key driving factors supporting the market growth. To learn more about the research report, download a sample report.
Overview
Gastrointestinal (GI) stents are specialized medical devices used to open and maintain the patency of obstructed or narrowed regions within the GI tract. These stents are typically inserted through minimally invasive endoscopic or radiological procedures and are commonly used to treat obstructions caused by malignancies, strictures, or other GI disorders. GI stents play a crucial role in restoring normal digestive function, reducing symptoms such as pain, nausea, or vomiting, and improving the quality of life, particularly for patients with advanced GI cancers or benign strictures. Some common types of gastrointestinal stents include esophageal, biliary, duodenal, colonic, pancreatic, and biodegradable and drug-eluting stents. Overall, gastrointestinal stents are essential interventional tools that offer significant clinical benefits by enabling non-surgical relief from GI obstructions and supporting effective palliative care in cancer patients.

To learn more about this report, download the PDF brochure
Rising GI disorders and demand for minimally invasive solutions fuel the market growth
The increasing global burden of GI cancers and non-malignant GI disorders significantly drives the gastrointestinal stent market. According to an article published in the NIH, GI cancers accounted for 4.8 million new cases and 3.4 million deaths in 2020, making them among the leading causes of cancer-related mortality worldwide. Also, according to the WHO, colorectal cancer alone was the third most commonly diagnosed cancer globally.
Further, non-cancerous GI conditions like gastroesophageal reflux disease (GERD), peptic ulcers, strictures, inflammatory bowel disease (IBD), and chronic pancreatitis are also on the rise. Factors contributing to the increasing prevalence of these conditions include sedentary lifestyles, poor dietary habits, and aging populations, among others. Additionally, the increasing incidences of both malignant and benign GI conditions are contributing to greater demand for therapeutic solutions like stents, which help restore lumen patency, reduce obstruction-related symptoms, and improve patient outcomes in both curative and palliative care settings.
Simultaneously, there is a growing shift toward minimally invasive procedures, such as esophageal stenting, driven by patients' preferences for faster recovery and fewer complications. Together, the rising prevalence of GI diseases and the increasing demand for less invasive treatment options are key factors propelling the adoption and expansion of the gastrointestinal stent market.

To learn more about this report, download the PDF brochure
Innovations in GI stents are advancing minimally invasive treatment options
The development of biodegradable and drug-eluting gastrointestinal (GI) stents marks a major step forward in endoscopic treatment for GI disorders. Traditional metal or plastic stents have been used to maintain patency in obstructed GI tracts; however, these materials often require secondary removal procedures and pose risks of infection, migration, and tissue injury. Biodegradable stents, composed of materials that naturally dissolve within the body over time, eliminate the need for stent retrieval, thereby reducing the risk of complications and improving patient comfort, especially in benign strictures which require temporary support.
Simultaneously, drug-eluting stents, which release therapeutic agents locally at the site of obstruction or stricture, offer targeted treatment, minimizing systemic side effects and improving clinical outcomes, particularly in cases involving malignancies, strictures, or inflammation. Together, these innovations enhance the therapeutic efficacy of stents, reduce hospital stays, and also align with the broader healthcare goals of minimally invasive intervention that improves quality of life for patients.
Competitive Landscape Analysis
The global gastrointestinal stent market comprises of several well-established and emerging players, including Boston Scientific Corporation; Cook Medical Inc.; Olympus Corporation; CONMED Corporation; Medtronic plc; ELLA-CS, s.r.o.; Becton, Dickinson and Company; Merit Medical Systems, Inc.; Hobbs Medical, Inc.; and W. L. Gore & Associates, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~6% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product Type, Application, Material, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Boston Scientific Corporation; Cook Medical Inc.; Olympus Corporation; CONMED Corporation; Medtronic plc; ELLA-CS, s.r.o.; Becton, Dickinson and Company; Merit Medical Systems, Inc.; Hobbs Medical, Inc.; and W. L. Gore & Associates, Inc.; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Â
Global Gastrointestinal Stent Market Segmentation
This report by Medi-Tech Insights provides the size of the global gastrointestinal stent market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type, application, material, and end-user.
Market Size & Forecast (2023-2030), By Product Type, USD Million
-
- Biliary Stents
- Colonic Stents
- Duodenal Stents
- Esophageal Stents
- Pancreatic Stents
Market Size & Forecast (2023-2030), By Application, USD Million
-
- Gastrointestinal Cancer
- Biliary Disease
- Colorectal Cancer
- Stomach Cancer
- Others
Market Size & Forecast (2023-2030), By Material, USD Million
-
- Plastic
- Metal
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
-
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the gastrointestinal stent market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the gastrointestinal stent market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Related Reports
Gastrointestinal Endoscopic Devices Market Size, Share, Trends & Growth Analysis 2025 to 2030
Global Gastrointestinal Devices Market Size & Trends Report Segmented by Product Type (GI endoscopes, Laparoscopes, Biopsy Devices, ERCP), Application (Diagnostic, Therapeutic), End-user (Hospitals, Diagnostic Centers) & Regional Forecast to 2030
Gastrointestinal Devices MedTech Market – Global Industry Analysis, Size, Share, Growth and Forecast 2025 to 2030
- Introduction
- Introduction​
- Market Scope​
- Market Definition​
- Segments Covered​
- Regional Segmentation​
- Research Timeframe​
- Currency Considered​
- Study Limitations​
- Stakeholders​
- List of Abbreviations​
- Key Conferences and Events (2025-2026)​
- Research Methodology​
- Secondary Research​
- Primary Research​
- Market Estimation​
- Bottom-Up Approach​
- Top-Down Approach​
- Market Forecasting​
- Executive Summary
- Gastrointestinal Stent Market Snapshot (2025-2030)​
- Segment Overview​
- Regional Snapshot​
- Competitive Insights ​
- Market Overview
- Market Dynamics
- Drivers
- Rising incidence of GI cancers and obstructions
- Growing geriatric population more prone to GI disorders
- Increasing preference for minimally invasive procedures
- Growing awareness and early diagnosis of GI disorders
- Advancements in stent design and material
- Restraints​
- High cost of advanced stents
- Lack of skilled professionals
- Risk of stent migration & complications
- Opportunities​
- Rising demand for palliative care in cancer management
- Development of biodegradable and drug-eluting stents
- Expansion in emerging markets with rising healthcare infrastructure
- Key Market Trends​
- Integration of AI in endoscopic procedures
- Shift towards patient-specific/customized stents
- Unmet Market Needs​
- Industry Speaks​
- Drivers
- Market Dynamics
- Global Gastrointestinal Stent Market Size & Forecast (2023-2030), By Product Type, USD Million
- Introduction​
- Biliary Stents
- Colonic Stents
- Duodenal Stents
- Esophageal Stents
- Pancreatic Stents
- Global Gastrointestinal Stent Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction​
- Gastrointestinal Cancer
- Biliary Disease
- Colorectal Cancer
- Stomach Cancer
- Others
- Global Gastrointestinal Stent Market Size & Forecast (2023-2030), By Material, USD Million
- Introduction​
- Plastic
- Metal
- Others
- Global Gastrointestinal Stent Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction​
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
- Global Gastrointestinal Stent Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction​
- North America Gastrointestinal Stent Market Size & Forecast (2023-2030), By Country, USD Million​
- US​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)​
- Market Size & Forecast, By End-user (USD Million)
- Canada​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US​
- Europe Gastrointestinal Stent Market Size & Forecast (2023-2030), By Country, USD Million​
- UK ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)​
- Rest of Europe ​
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By Application (USD Million)​​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK ​
- Asia Pacific (APAC) Gastrointestinal Stent Market Size & Forecast (2023-2030), By Country, USD Million​
- China ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)​
- Japan ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)​
- Rest of Asia Pacific ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China ​
- Latin America (LATAM) Gastrointestinal Stent Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By Material (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Gastrointestinal Stent Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Material (USD Million)​
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Boston Scientific Corporation
- Cook Medical Inc.
- Olympus Corporation
- CONMED Corporation
- Medtronic plc
- ELLA-CS, s.r.o.
- Becton, Dickinson and Company
- Merit Medical Systems, Inc.
- Hobbs Medical, Inc.
- L. Gore & Associates, Inc.
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)

Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Specialty Clinics, ASCs, and Others
Breakdown of Primary Interviews

Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
Features of the Report
- Comprehensive Market Coverage
- Market Size and Forecast
- Geographic & Segment Deep Dives
- Strategic Insights & Competitive Landscape
- Timely & Updated Data
- Growth Indicators & Future Outlook
- Quick Turnaround on Queries
- Analyst Support
- Report Customization Available
- Reports in PDF & Excel


